Immunotherapy
AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy
AIVITA Biomedical
PR-M02-19-NI-031Feb 14, 2019
Immunotherapy
AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
AIVITA Biomedical
PR-M01-19-NI-056Jan 18, 2019
Clinical Trials
AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial
AIVITA Biomedical
PR-M11-18-NI-073-3354Nov 21, 2018